promise and challenges of RNA-targeted therapeutics in preventive cardiology
Despite landmark achievements made in the past 50 years to understand, treat, and prevent atherosclerotic cardiovascular diseases (ACVD), preventing heart attac
Related Articles
Question: Surviving the storm: ventricular fibrillation in the left ventricle assist device era
This Spot the Diagnosis article refers to ‘Answer: Surviving the storm: ventricular fibrillation in the left ventricle assist device era’, by G. Campos et
Fatal intramyocardial dissecting hematoma caused by coronary artery perforation during percutaneous coronary intervention
Hiroki Yamanobe, MD, Kensaku Nishihira, MD, PhD, Mitsuhiro Yano, MD, PhD, Yoshisato Shibata, MD, Yujiro Asada, MD, PhD; Fatal intramyocardial dissecting he
Glucagon-like peptide-1 receptor agonists use and associations with outcomes in heart failure and type 2 diabetes. Data from the Swedish Heart Failure and Swedish National Diabetes Registries
AbstractAims. To assess use and associations with outcomes of glucagon-like peptide-1 receptor agonists (GLP-1 RA) in a real-world population with heart fa
Hypertrophic cardiomyopathy detection with artificial intelligence electrocardiography in international cohorts: an external validation study
AbstractAim. Recently, deep-learning artificial intelligence (AI) models have been trained to detect cardiovascular conditions, including hypertrophic card
Development and external validation of a dynamic risk score for early prediction of cardiogenic shock in cardiac intensive care units using machine learning
AbstractAims. Myocardial infarction and heart failure are major cardiovascular diseases that affect millions of people in the USA with morbidity and mortal
Remote Rhythm Monitoring using a Photoplethysmography Smartphone Application after Cardioversion for Atrial Fibrillation
AbstractIntroduction. Direct current cardioversion (DCCV) is a commonly utilised rhythm control technique for atrial fibrillation (AF). Follow-up typically
Contemporary trends in incident ischemic stroke, intracranial hemorrhage, and mortality in individuals with atrial fibrillation
AbstractBackground. The prognosis for atrial fibrillation (AF) patients is based on data that is decades old. Given evolving standards of clinical practice
Safety and effectiveness of glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: insights from the SPUM-ACS study
AbstractAims. Data on Glycoprotein IIb/IIIa inhibitors (GPI) use in real world ACS patients following the introduction of potent P2Y12 inhibitors and newer
Stem cell factor and cKIT modulate endothelial glycolysis in hypoxia
AbstractAims. In hypoxia, endothelial cells (ECs) proliferate, migrate, and form new vasculature in a process called angiogenesis. Recent studies have sugg
Digital recruitment and compliance to treatment recommendations in the Norwegian Atrial Fibrillation self-screening pilot study
AbstractBackground. Atrial fibrillation (AF) is prevalent, undiagnosed in approximately one-third of cases, and is associated with severe complications. Gu